Krystal Biotech Inc (1KRYS)

Currency in EUR
129.60
0.00(0.00%)
Real-time Data·
1KRYS Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
1KRYS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
129.60129.60
52 wk Range
113.75133.25
Key Statistics
Prev. Close
129.6
Open
129.6
Day's Range
129.6-129.6
52 wk Range
113.75-133.25
Volume
-
Average Volume (3m)
65
1-Year Change
-
Book Value / Share
31.6
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
1KRYS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Krystal Biotech Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Krystal Biotech Inc Company Profile

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB105, which is in Phase 1/2 clinical trials for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for treating netherton syndrome; KB407 that is in Phase 1 clinical trials for treating cystic fibrosis; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.

Industry
-
Sector
-
Employees
275
Market
Italy

Compare 1KRYS to Peers and Sector

Metrics to compare
1KRYS
Peers
Sector
Relationship
P/E Ratio
35.8x−4.1x−0.5x
PEG Ratio
0.32−0.200.00
Price/Book
4.5x1.9x2.6x
Price / LTM Sales
13.3x9.4x3.2x
Upside (Analyst Target)
-72.2%41.2%
Fair Value Upside
Unlock15.5%6.2%Unlock

Earnings

Latest Release
May 06, 2025
EPS / Forecast
1.20 / --
Revenue / Forecast
88.18M / --
EPS Revisions
Last 90 days

1KRYS Income Statement

People Also Watch

14.96
ARQT
+0.67%
16.20
ARWR
+2.92%
26.86
CNC
-5.39%
14.67
OSCR
+1.52%
43.630
VIST
-1.96%

FAQ

What Stock Exchange Does Krystal Biotech Inc Trade On?

Krystal Biotech Inc is listed and trades on the Milan Stock Exchange stock exchange.

What Is the Stock Symbol for Krystal Biotech Inc?

The stock symbol for Krystal Biotech Inc is "1KRYS."

What Is the Krystal Biotech Inc Market Cap?

As of today, Krystal Biotech Inc market cap is 3.82B.

What Is Krystal Biotech Inc's Earnings Per Share (TTM)?

The Krystal Biotech Inc EPS (TTM) is 4.32.

From a Technical Analysis Perspective, Is 1KRYS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Krystal Biotech Inc Stock Split?

Krystal Biotech Inc has split 0 times.

How Many Employees Does Krystal Biotech Inc Have?

Krystal Biotech Inc has 275 employees.

What is the current trading status of Krystal Biotech Inc (1KRYS)?

As of 29 Jul 2025, Krystal Biotech Inc (1KRYS) is trading at a price of 129.60, with a previous close of 129.60. The stock has fluctuated within a day range of 129.60 to 129.60, while its 52-week range spans from 113.75 to 133.25.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.